Search - tctmd.com

Displaying 321 - 340 of 351

Presentation TCT 2013

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Presenter: Eui Im, Byeong-Keuk Kim, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 31, 2013

Presentation TCT 2013

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Presenter: Piotr Buszman, Taylor Palmieri, Maxwell Afari, Armando Tellez, Yanping Cheng, Jong Shiuan Yeh, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Presenter: Maxwell Afari, Seung-Jin Oh, Piotr Buszman, Armando Tellez, Athanasios Peppas, William Rate, Jong Shiuan Yeh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Incidence and Characterization of Stent Dissections in Women Versus Men: A Report from the Massachusetts General Hospital Optical Coherence Tomography Registry.

Presenter: Magdalena Zeglin-Sawczuk, Ik-Kyung Jang, Taka Ashikaga, Koji Kato, Taishi Yonetsu, So-Yeon Choi, Soo Joong Kim, Christina Kratlian, Hang Lee, Harold Dauerman

January 31, 2013

Presentation TCT 2013

Frequency and Type of Neoatherosclerosis Five Years After Drug-Eluting Stent Implantation: an Optical Coherence Tomography Study

Presenter: Masanori Taniwaki, Lorenz R?ber, Sandro Baumgartner, Thomas Pilgrim, Aris Moschovitis, Peter Wenaweser, Bernhard Meier, Stephan Windecker

January 31, 2013

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Presenter: Evelyn Regar

October 25, 2012

Presentation TCT 2012

Case 1: OCT Case

Presenter: Jingbo Hou

October 25, 2012

Presentation TCT 2012

OCT to Risk Stratify and Guide PCI Procedures 2: Postintervention Assessment

Presenter: Francesco Prati

October 25, 2012

Presentation TCT 2012

OCT to Risk Stratify and Guide PCI Procedures 1: Preintervention Assessment

Presenter: Takashi Kubo

October 25, 2012

Presentation TCT 2012

TCT-17. Serial Changes of Everolimus-Eluting Stent Malapposition: An Optical Coherence Tomography Subanalysis from the RESET Trial

Presenter: Kunihiro Shimamura

October 23, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

Presentation ACVS 2012

OCT and Other Intravascular Imaging Modalities

Presenter: Amal Louis

August 05, 2012

News Daily News

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

L.A. McKeown

July 05, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

Presentation

Incidence and Time Course of Neoatherosclerosis Between BMS and DES Using OCT

Presenter: T. Yonetsu

July 03, 2012

Presentation TCT Russia 2012

Coronary Bifurcation Treatment: Strut Apposition by OCT

Presenter: Carlo Di Mario

May 28, 2012

News Conference News EuroPCR 2012

OCT-Guided PCI Improves 1-Year Outcomes vs. Angiography Alone

Jason Kahn

May 18, 2012

Presentation EuroPCR 2012

ISAR‐TEST‐6 OCT

Presenter: Julinda Mehilli

May 16, 2012

Presentation EuroPCR 2012

Angiography alone versus angiography plus optical coherence tomography to guide decision making during percutaneous coronary intervention: the CLI-OPCI study

Presenter: Francesco Prati

May 16, 2012

Presentation Fellows 2012

Optical Coherence Tomographic Imaging in the Cath Lab: When and Why

Presenter: Akiko Maehara

April 20, 2012

Advertisement

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Incidence and Characterization of Stent Dissections in Women Versus Men: A Report from the Massachusetts General Hospital Optical Coherence Tomography Registry.

Frequency and Type of Neoatherosclerosis Five Years After Drug-Eluting Stent Implantation: an Optical Coherence Tomography Study

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Case 1: OCT Case

OCT to Risk Stratify and Guide PCI Procedures 2: Postintervention Assessment

OCT to Risk Stratify and Guide PCI Procedures 1: Preintervention Assessment

TCT-17. Serial Changes of Everolimus-Eluting Stent Malapposition: An Optical Coherence Tomography Subanalysis from the RESET Trial

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

OCT and Other Intravascular Imaging Modalities

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

DES Show More Neoatherosclerosis Than BMS Over 4 Years

Incidence and Time Course of Neoatherosclerosis Between BMS and DES Using OCT

Coronary Bifurcation Treatment: Strut Apposition by OCT

OCT-Guided PCI Improves 1-Year Outcomes vs. Angiography Alone

ISAR‐TEST‐6 OCT

Angiography alone versus angiography plus optical coherence tomography to guide decision making during percutaneous coronary intervention: the CLI-OPCI study

Optical Coherence Tomographic Imaging in the Cath Lab: When and Why

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content